Related Experiment Video
Updated: Dec 19, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Microbiota and cardiovascular disease risk: A scoping review
Federico Scarmozzino1, Andrea Poli2, Francesco Visioli3
1Department of Molecular Medicine, University of Padova, Italy.
The gut and oral microbiota influence cardiovascular risk by altering food compounds and producing metabolites. Future cardio-prevention strategies include inhibiting harmful microbial molecules and using probiotics and prebiotics.
Area of Science:
- Microbiology
- Cardiovascular Science
- Nutritional Science
Background:
- Emerging research highlights the significant role of oral and intestinal microbiota in cardiovascular risk.
- The relationship between diet and microbiota is bidirectional, impacting health through metabolite production.
Purpose of the Study:
- To review current evidence on microbiota-cardiovascular risk interactions.
- To explore future cardio-preventive strategies targeting the microbiota.
Main Methods:
- Scoping review of scientific literature.
- Focus on oral and intestinal microbiota research.
- Analysis of microbiota-food interactions and metabolite effects.
Main Results:
- Convincing evidence supports microbiota's influence on cardiovascular risk.
- Microbiota can modify food compounds, leading to atherogenic or protective effects.
- Specific bacterial strains and prebiotics can directly impact atherogenesis.
Conclusions:
- Targeting microbiota-derived molecules offers a promising cardio-preventive approach.
- Personalized diets and supplements based on metabotype screening are future possibilities.
- Microbiota modulation using pro- and prebiotics presents a therapeutic avenue.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Endocarditis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

